Aug 3 |
Even after rising 8.9% this past week, NovoCure (NASDAQ:NVCR) shareholders are still down 86% over the past three years
|
Aug 1 |
New Strong Buy Stocks for August 1st
|
Jul 30 |
Wall Street Analysts Believe NovoCure (NVCR) Could Rally 26.39%: Here's is How to Trade
|
Jul 26 |
NovoCure Limited: A Post Q2 Analysis
|
Jul 25 |
NovoCure (NVCR) Q2 2024 Earnings Call Transcript
|
Jul 25 |
NovoCure Limited (NVCR) Q2 2024 Earnings Call Transcript
|
Jul 25 |
NovoCure Limited 2024 Q2 - Results - Earnings Call Presentation
|
Jul 25 |
NovoCure (NVCR) Reports Q2 Loss, Tops Revenue Estimates
|
Jul 25 |
NovoCure: Q2 Earnings Snapshot
|
Jul 25 |
NovoCure GAAP EPS of -$0.31 beats by $0.09, revenue of $150.4M beats by $14.57M
|